164 related articles for article (PubMed ID: 26103543)
21. TNF inhibitors for rheumatoid arthritis - a year in review.
Simsek I
Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
[TBL] [Abstract][Full Text] [Related]
22. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
Van Doornum S; McColl G; Wicks IP
Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
[TBL] [Abstract][Full Text] [Related]
23. Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Leporini C; Russo E; D Angelo S; Arturi F; Tripepi G; Peluso R; Grembiale RD; Olivieri I; De Sarro G; Ursini F
Rev Recent Clin Trials; 2018; 13(3):184-191. PubMed ID: 29542420
[TBL] [Abstract][Full Text] [Related]
24. Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus?
Bongartz T; Kudva Y
JAMA; 2011 Jun; 305(24):2573-4. PubMed ID: 21693749
[No Abstract] [Full Text] [Related]
25. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
Murdaca G; Spanò F; Puppo F
Expert Opin Drug Saf; 2013 Nov; 12(6):801-4. PubMed ID: 23889669
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis.
Tocci G; Goletti D; Marino V; Matucci A; Milano GM; Cantini F; Scarpa R
Expert Opin Drug Saf; 2016 Dec; 15(sup1):55-61. PubMed ID: 27924645
[TBL] [Abstract][Full Text] [Related]
27. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
Kotyla PJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895751
[TBL] [Abstract][Full Text] [Related]
28. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
30. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.
Wasko MC; Kay J; Hsia EC; Rahman MU
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):512-21. PubMed ID: 21452264
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system involvement in rheumatoid arthritis: possible role of chronic inflammation and tnf blocker therapy.
Sağ S; Sağ MS; Tekeoğlu I; Kamanlı A; Nas K; Acar BA
Acta Neurol Belg; 2020 Feb; 120(1):25-31. PubMed ID: 29288410
[TBL] [Abstract][Full Text] [Related]
33. Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
Güler-Yüksel M; Allaart CF; Watt I; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Schaardenburg D; van Krugten MV; Dijkmans BA; Huizinga TW; Lems WF; Kloppenburg M
Osteoarthritis Cartilage; 2010 Oct; 18(10):1256-62. PubMed ID: 20691795
[TBL] [Abstract][Full Text] [Related]
34. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
Dulai R; Perry M; Twycross-Lewis R; Morrissey D; Atzeni F; Greenwald S
Semin Arthritis Rheum; 2012 Aug; 42(1):1-8. PubMed ID: 22475245
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
Mayer Y; Balbir-Gurman A; Machtei EE
J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
[TBL] [Abstract][Full Text] [Related]
36. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy.
Bibbo C; Goldberg JW
Foot Ankle Int; 2004 May; 25(5):331-5. PubMed ID: 15134615
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.
Al-Aly Z; Pan H; Zeringue A; Xian H; McDonald JR; El-Achkar TM; Eisen S
Transl Res; 2011 Jan; 157(1):10-8. PubMed ID: 21146146
[TBL] [Abstract][Full Text] [Related]
38. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
39. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Aramaki T; Nakashima M; Fujikawa K; Tsukada T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A
Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075
[TBL] [Abstract][Full Text] [Related]
40. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
Park HJ; Ranganathan P
Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
